HealthcareMarket

Stada CEO Anticipates Robust Investor Interest for Upcoming European IPO

4 months ago

Stada, a prominent European pharmaceutical company, is gearing up for what is anticipated to be one of the region's largest initial public offerings (IPOs) in recent history. CEO Peter Goldschmidt shared insights about the IPO process during a recent interview, projecting strong demand from investors keen on entering the pharmaceutical sector. The company's potential listing has captured attention amidst a slowly recovering stock market and an increasing appetite for shares in the healthcare industry.

Lilly Faces Sales Setback Amid Disappointing Weight Loss Drug Performance

7 months ago

Pharmaceutical giant Eli Lilly has reported a decline in its sales figures for the third quarter of 2024, primarily attributed to the underperformance of its weight-loss drug, a critical component of its recent growth strategy. Despite the company’s robust portfolio, the latest earnings report fell short of analysts' anticipations, leading to concerns about future growth and profitability.